Oral and maxillofacial manifestations of human immunodefficiency virus infection

Autor: Benslama, L.

Publikováno v: In Journal of Stomatology oral and Maxillofacial Surgery November 2022 123(6):622-633

Anterior pedicle temporalis muscle flap interposition in the treatment of TMJ disorders

Autor: Moreau, A., Benassarou, M.-A., Benslama, L., Goudot, P., Schoumann, T.

Publikováno v: In Journal of Stomatology oral and Maxillofacial Surgery September 2018 119(4):325-327

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Kimura's disease of the hard palate

Autor: Benslama, L., Labrousse, D., Gruffaz, F., Goudot, Patrick

Publikováno v: Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale
Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale, Société Française de Stomatologie Chirurgie Maxillo-faciale et de Chirurgie Orale (SFSCMFCO) / Elsevier, 2016, 117 (2), pp.101-103. ⟨10.1016/j.revsto.2016.01.004⟩
Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale, 2016, 117 (2), pp.101-103. ⟨10.1016/j.revsto.2016.01.004⟩

International audience; Introduction. Kimura's disease is an inflammatory and autoimmune disease that is endemic in Middle East and Asian countries but remains rare in Europe. It usually presents as subcutaneous nodules combined with cervical lymphad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d3965beedac4e67311a11233669c30dc
https://hal.archives-ouvertes.fr/hal-01545732

The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008

Autor: Gathmann B., Grimbacher B., Beauté J., Dudoit Y., Mahlaoui N., Fischer A., Knerr V., Kindle G., Micol R., Benslama L., Plebani A., Notarangelo L., PIGNATA, CLAUDIO, Bangs C., Lucas M., Tierney P., Core C., Dempster J., Exley A., Kumararatne D., Paschenko O., Kondratenko I., Shcherbina A., Velbri S., Ciznar P., Duobiene R., Kilic S., Kütükcüler N., Sanal O., Reisli I., Yegin O., Kanariou M., Papadopoulou Alataki E., Trachana M., Hatzistilianou M., Farber C.M., Meyts I., Pasic S., Richter D., Marodi L., Touitou I., Abuzakouk M., Feighery C., Thon V., Litzman J., Cucuruz M., Wolska B., Szaflarska A., Reda S., Soler P., Caragol I., Llobet P., Savchak I., Marques L., Koren A., Hörnes M., Shchebet S., Goldacker S., Ritterbusch H., Fasshauer M., Sollinger F., Witte T., Baumann U., Wittkowski H., Viemann D., Niehues T., Stimm H., Brodszki N.

Publikováno v: Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2009, 157 (suppl 1), pp.3-11. ⟨10.1111/j.1365-2249.2009.03954.x⟩

Summary Primary immunodeficiencies (PID) are rare diseases; therefore transnational studies are essential to maximize the scientific outcome and to improve diagnosis and therapy. In order to estimate the prevalence of PID in Europe as well as to esta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c5a7e2fd1c598972d9fa684f03e3ad
https://hal.archives-ouvertes.fr/hal-00429339